Considering the relatively specific expression of ATF5 in malignant T cells, we evaluated the clinical relevance of ATF5 expression in a cohort of 49 tumor-stage CTCL patients with bulk RNA sequencing data which was published by our group previously (29). Here, ATF5 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.